What is the prevalence of Vestibular Schwannoma-Acoustic neuroma?
How many people does Vestibular Schwannoma-Acoustic neuroma affect? Does it have the same prevalence in men and women? And in the different countries?
The prevalence of Vestibular Schwannoma, also known as Acoustic neuroma, is estimated to be approximately 1 in every 100,000 individuals. This benign tumor typically arises from the Schwann cells of the vestibular nerve, affecting the hearing and balance functions. While it can occur at any age, it is most commonly diagnosed between the ages of 30 and 60. Early detection and treatment are crucial for managing the condition and minimizing potential complications. If you suspect any symptoms related to hearing loss or balance issues, it is important to consult a healthcare professional for proper evaluation and guidance.
Vestibular Schwannoma, also known as Acoustic neuroma, is a relatively rare benign tumor that develops on the vestibular nerve, which connects the inner ear to the brain. It arises from Schwann cells, which are responsible for the myelin sheath surrounding nerve fibers. While the exact cause is unknown, it is believed to be associated with a genetic condition called neurofibromatosis type 2 (NF2) in some cases.
The prevalence of Vestibular Schwannoma varies depending on the population studied. It is estimated to occur in approximately 1 in 100,000 individuals per year. However, the incidence increases with age, with the highest occurrence observed in individuals aged 30-60 years. It affects both males and females equally.
Although Vestibular Schwannoma is considered a rare tumor, it is important to note that it is the most common type of tumor affecting the cranial nerves. The tumor typically grows slowly, causing symptoms such as hearing loss, tinnitus, dizziness, and balance problems. Early detection and appropriate management are crucial for preserving hearing and preventing complications.
